Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Long Term Investor Alert: Investigation of Potential Wrongdoing
An investigation was announced long-term investors in shares of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) concerning potential breaches of fiduciary duties by certain directors of Eiger BioPharmaceuticals, Inc.
View full press release